About cstone pharmaceuticals co ltd - CSPHF
Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. Its products include immuno-oncology drugs and molecularly targeted drugs. The company was founded on December 2, 2015, and is headquartered in Shanghai, China.
CSPHF At a Glance
CStone Pharmaceuticals Co. Ltd.
North Block Suzhou Industrial Park
Shanghai, Shanghai 200126
| Phone | 86-21-6109-7678 | Revenue | 37.50M | |
| Industry | Pharmaceuticals: Major | Net Income | -60,792,398.61 | |
| Sector | Health Technology | Employees | 93 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
CSPHF Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 25.066 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -15.878 |
| Enterprise Value to Sales | 22.891 |
| Total Debt to Enterprise Value | 0.058 |
CSPHF Efficiency
| Revenue/Employee | 403,250.035 |
| Income Per Employee | -653,681.706 |
| Receivables Turnover | 7.751 |
| Total Asset Turnover | 0.195 |
CSPHF Liquidity
| Current Ratio | 2.182 |
| Quick Ratio | 1.953 |
| Cash Ratio | 1.801 |
CSPHF Profitability
| Gross Margin | 17.054 |
| Operating Margin | -160.478 |
| Pretax Margin | -157.257 |
| Net Margin | -162.103 |
| Return on Assets | -31.557 |
| Return on Equity | -88.035 |
| Return on Total Capital | -44.01 |
| Return on Invested Capital | -61.855 |
CSPHF Capital Structure
| Total Debt to Total Equity | 56.507 |
| Total Debt to Total Capital | 36.105 |
| Total Debt to Total Assets | 25.657 |
| Long-Term Debt to Equity | 25.444 |
| Long-Term Debt to Total Capital | 16.257 |